Furthermore, we examined the effect of STAT3 inhibitor, S31-201 on the NE-induced IL-6/IL-6R trans-signaling, and identified that STAT3 inhibitor significantly inhibited the NE and IL-6R-induced collagen type I production in the SSc fibroblasts (Fig. 5C). This evidence concerns the gene STAT3 and systemic sclerosis.